SERAFs grant from the Research Council of Norway enables SERAF to perform clinical addiction research at an international level and contributes to a more sufficient, evidence-based treatment of addiction disorders.
To meet the request from the research council we have significantly increased our alcohol research. We conduct extensive dissemination of addiction research through publications, lectures, courses, supervision and teaching of master and PhD students.
SERAF has a broad national and international network in the field of clinical addiction research.
Half of substance users have recently been victims of crime
Nov. 16, 2017 1:18 PM
Victimization was associated with symptoms of poor mental health, more serious substance use and unstable housing.
Extended-release naltrexone as effective as buprenorphine-naloxone on retention in treatment and reducing use of heroin and other Illicit opioids in head-to-head comparison trial
Oct. 20, 2017 11:57 AM
In the 12-week, open-label, randomized-controlled study, 159 patients with opioid dependence were randomized to treatment with either extended-release naltrexone or buprenorphine-naloxone, following detoxification.
Abstinent networks contribute to increased quality of life
Oct. 5, 2017 9:58 AM
A new article from the NorComt study at SERAF examine how patients are doing one year after starting in treatment and investigate the impact of abstinent networks.
- Stimulant medication for ADHD in opioid maintenance treatment Dec. 1, 2014 12:02 PM
- From methadone to buprenorphine: Changes during a 10 year period within a national opioid maintenance treatment programme Sep. 18, 2014 3:33 PM
- Motivational intervention to enhance post-detoxification 12-Step group affiliation: a randomized controlled trial Sep. 18, 2014 3:24 PM